SMT201900101T1 - Composto eterociclico - Google Patents
Composto eterociclicoInfo
- Publication number
- SMT201900101T1 SMT201900101T1 SM20190101T SMT201900101T SMT201900101T1 SM T201900101 T1 SMT201900101 T1 SM T201900101T1 SM 20190101 T SM20190101 T SM 20190101T SM T201900101 T SMT201900101 T SM T201900101T SM T201900101 T1 SMT201900101 T1 SM T201900101T1
- Authority
- SM
- San Marino
- Prior art keywords
- heterocyclic compound
- heterocyclic
- compound
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013224093 | 2013-10-29 | ||
| EP14800152.2A EP3063139B1 (en) | 2013-10-29 | 2014-10-28 | Heterocyclic compound |
| PCT/JP2014/005438 WO2015064083A1 (en) | 2013-10-29 | 2014-10-28 | Heterocyclic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201900101T1 true SMT201900101T1 (it) | 2019-02-28 |
Family
ID=51932560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM20190101T SMT201900101T1 (it) | 2013-10-29 | 2014-10-28 | Composto eterociclico |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9120777B2 (OSRAM) |
| EP (1) | EP3063139B1 (OSRAM) |
| JP (1) | JP6450755B2 (OSRAM) |
| AR (2) | AR098215A1 (OSRAM) |
| CY (1) | CY1121279T1 (OSRAM) |
| DK (1) | DK3063139T3 (OSRAM) |
| ES (1) | ES2710657T3 (OSRAM) |
| HR (1) | HRP20190133T1 (OSRAM) |
| HU (1) | HUE041792T2 (OSRAM) |
| LT (1) | LT3063139T (OSRAM) |
| PL (1) | PL3063139T3 (OSRAM) |
| PT (1) | PT3063139T (OSRAM) |
| RS (1) | RS58321B1 (OSRAM) |
| SI (1) | SI3063139T1 (OSRAM) |
| SM (1) | SMT201900101T1 (OSRAM) |
| TR (1) | TR201901986T4 (OSRAM) |
| TW (1) | TWI668214B (OSRAM) |
| UY (1) | UY35801A (OSRAM) |
| WO (1) | WO2015064083A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2816032A4 (en) * | 2012-02-13 | 2015-09-30 | Takeda Pharmaceutical | AROMATIC RING CONNECTION |
| ES2629729T3 (es) * | 2013-03-14 | 2017-08-14 | Takeda Pharmaceutical Company Limited | Derivados de espiro azetidina asoxazol y uso de los mismos como antagonistas de sstr5 |
| JO3442B1 (ar) | 2013-10-07 | 2019-10-20 | Takeda Pharmaceuticals Co | مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5) |
| WO2021123145A1 (en) * | 2019-12-19 | 2021-06-24 | Universite De Strasbourg | Sigma-1 receptor ligands and uses thereof |
| CN116354961B (zh) * | 2021-12-27 | 2025-07-25 | 中国科学院上海药物研究所 | 生长抑素受体5拮抗剂及其药物组合物及用途 |
| WO2024204277A1 (ja) | 2023-03-27 | 2024-10-03 | 株式会社スコヒアファーマ | 成長ホルモン分泌促進剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356906A (en) | 1989-10-27 | 1994-10-18 | The Du Pont Merck Pharmaceutical Company | (N-phthalimidoalkyl) piperidines useful as treatments for psychosis |
| KR100904011B1 (ko) | 2000-06-12 | 2009-06-22 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 1,2-디하이드로피리딘 화합물 및 그의 제조 방법 |
| GB0129260D0 (en) | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
| TW201018661A (en) | 2003-03-14 | 2010-05-16 | Ono Pharmaceutical Co | Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient |
| RU2006120084A (ru) | 2003-11-10 | 2008-01-10 | Шеринг Акциенгезельшафт (De) | Бензилэфирамины, полезные как антагонисты ccr-5 |
| US7754744B2 (en) * | 2006-08-15 | 2010-07-13 | Hoffmann-La Roche Inc. | Substituted piperidinamines as somatostatin receptor subtype 5 (SSTR5) antagonists |
| US7862825B2 (en) | 2007-02-21 | 2011-01-04 | Mladen Vranic | Method of controlling tight blood glucose by somatostatin receptor antagonists |
| US7799806B2 (en) * | 2007-04-04 | 2010-09-21 | Hoffmann-La Roche Inc. | Substituted n-benzyl piperidines as somatostatin receptor modulators |
| US20080306116A1 (en) | 2007-06-08 | 2008-12-11 | Christ Andreas D | Aryloxazole, aryloxadiazole and benzimidazole derivatives |
| TW200918062A (en) | 2007-09-12 | 2009-05-01 | Wyeth Corp | Azacyclylisoquinolinone and-isoindolinone derivatives as histamine-3 antagonists |
| WO2010129729A1 (en) | 2009-05-07 | 2010-11-11 | Merck Sharp & Dohme Corp. | Substituted spirocyclic amines useful as antidiabetic compounds |
| EP2605658B1 (en) | 2010-08-18 | 2016-03-23 | Merck Sharp & Dohme Corp. | Spiroxazolidinone compounds |
| US9000175B2 (en) | 2010-11-26 | 2015-04-07 | Lupin Limited | Bicyclic GPR119 modulators |
| ES2629729T3 (es) | 2013-03-14 | 2017-08-14 | Takeda Pharmaceutical Company Limited | Derivados de espiro azetidina asoxazol y uso de los mismos como antagonistas de sstr5 |
-
2014
- 2014-10-28 US US14/525,593 patent/US9120777B2/en active Active
- 2014-10-28 HR HRP20190133TT patent/HRP20190133T1/hr unknown
- 2014-10-28 WO PCT/JP2014/005438 patent/WO2015064083A1/en not_active Ceased
- 2014-10-28 UY UY0001035801A patent/UY35801A/es not_active Application Discontinuation
- 2014-10-28 JP JP2016526960A patent/JP6450755B2/ja active Active
- 2014-10-28 AR ARP140104043A patent/AR098215A1/es active IP Right Grant
- 2014-10-28 HU HUE14800152A patent/HUE041792T2/hu unknown
- 2014-10-28 RS RS20190190A patent/RS58321B1/sr unknown
- 2014-10-28 PT PT14800152T patent/PT3063139T/pt unknown
- 2014-10-28 ES ES14800152T patent/ES2710657T3/es active Active
- 2014-10-28 EP EP14800152.2A patent/EP3063139B1/en active Active
- 2014-10-28 LT LTEP14800152.2T patent/LT3063139T/lt unknown
- 2014-10-28 PL PL14800152T patent/PL3063139T3/pl unknown
- 2014-10-28 TW TW103137143A patent/TWI668214B/zh active
- 2014-10-28 SI SI201431055T patent/SI3063139T1/sl unknown
- 2014-10-28 DK DK14800152.2T patent/DK3063139T3/en active
- 2014-10-28 TR TR2019/01986T patent/TR201901986T4/tr unknown
- 2014-10-28 SM SM20190101T patent/SMT201900101T1/it unknown
-
2019
- 2019-02-14 CY CY20191100202T patent/CY1121279T1/el unknown
-
2022
- 2022-12-29 AR ARP220103645A patent/AR128158A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RS58321B1 (sr) | 2019-03-29 |
| DK3063139T3 (en) | 2019-03-11 |
| TW201542539A (zh) | 2015-11-16 |
| PL3063139T3 (pl) | 2019-05-31 |
| HUE041792T2 (hu) | 2019-05-28 |
| CY1121279T1 (el) | 2020-05-29 |
| LT3063139T (lt) | 2019-02-25 |
| JP6450755B2 (ja) | 2019-01-09 |
| AR098215A1 (es) | 2016-05-18 |
| EP3063139B1 (en) | 2018-11-21 |
| UY35801A (es) | 2015-06-30 |
| US9120777B2 (en) | 2015-09-01 |
| SI3063139T1 (sl) | 2019-03-29 |
| TWI668214B (zh) | 2019-08-11 |
| ES2710657T3 (es) | 2019-04-26 |
| US20150119412A1 (en) | 2015-04-30 |
| WO2015064083A1 (en) | 2015-05-07 |
| TR201901986T4 (tr) | 2019-03-21 |
| AR128158A2 (es) | 2024-03-27 |
| EP3063139A1 (en) | 2016-09-07 |
| HRP20190133T1 (hr) | 2019-03-22 |
| JP2016535040A (ja) | 2016-11-10 |
| PT3063139T (pt) | 2019-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249518B (en) | A compound that inhibits trk | |
| EP3026051A4 (en) | Heterocyclic compound | |
| GB201311891D0 (en) | Novel compound | |
| EP3029031A4 (en) | Heterocyclic compound | |
| AP2015008713A0 (en) | Tetrahydropyrrolothiazine compounds | |
| GB201302927D0 (en) | Compounds | |
| SG11201600759XA (en) | Novel quinoline-substituted compound | |
| GB201302368D0 (en) | Compound | |
| IL245301A0 (en) | New heterocyclic compounds | |
| ZA201507044B (en) | Pyridinylpyrazoloquinoline compound | |
| EP2975031A4 (en) | Heterocyclic compound | |
| EP3061754A4 (en) | Heterocyclic compound | |
| AP3850A (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| HUE041792T2 (hu) | Heterociklusos vegyület | |
| IL241962B (en) | Heterocyclic acetamide compound | |
| EP2948457A4 (en) | COMPOUNDS | |
| GB201307331D0 (en) | Compound | |
| GB201408643D0 (en) | Compound | |
| GB201322438D0 (en) | Compound | |
| GB201315772D0 (en) | Compound | |
| GB201305634D0 (en) | Compound | |
| GB201304250D0 (en) | Compound | |
| GB201301585D0 (en) | Compound | |
| GB201314960D0 (en) | Heterocyclic derivatives | |
| GB201300306D0 (en) | Heterocyclic derivatives |